Showing results (941-950 of 1,388) with videos related to

Sort By:
Pageof 139
Ophthalmology and Therapy|April 21, 2025
Large Language Models: Pioneering New Educational Frontiers in Childhood MyopiaMohammad Delsoz, Amr Hassan, Amin Nabavi, et al.
Ophthalmology and Therapy|April 25, 2025
Latanoprostene Bunod 0.024% Early Experience Program (LEEP): A Canadian Initiative for Open-Angle Glaucoma and Ocular HypertensionDavid Yan, Cindy M L Hutnik, Paul Harasymowycz
Ophthalmology and Therapy|June 15, 2023
Artificial Intelligence-Based Quantification of Central Macular Fluid Volume and VA Prediction for Diabetic Macular Edema Using OCT ImagesXin Ye, Kun Gao, Shucheng He, et al.
Ophthalmology and Therapy|June 13, 2023
Adherence and Persistence to Medical Therapy in Glaucoma: An OverviewLuciano Quaranta, Alessio Novella, Mauro Tettamanti, et al.
Ophthalmology and Therapy|March 14, 2026
Immunomodulation of the Ocular Surface in Severe Dry Eye Disease: Expert-Driven Literature Review on Treatment Strategies with Description of Representative Challenging CasesGiuseppe Giannaccare, Botagoz Issergepova, Maciej Kozak, et al.
Ophthalmology and Therapy|March 13, 2026
Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug DurabilityRobert Avery, Cheikh Diack, Nancy Holekamp, et al.
Ophthalmology and Therapy|March 15, 2026
Safety and Feasibility of the Exchange Procedure for the Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular HypertensionJohn P Berdahl, Robert P Lehmann, Jason J Jones, et al.
Ophthalmology and Therapy|February 21, 2026
Retinal Arterial Vasospasm in Retinal Vein Occlusion and Its Association with Aqueous Humor Endothelin-1SolAh Han, Chau Thi Ngoc Tran, Jee Myung Yang, et al.
Ophthalmology and Therapy|February 19, 2026
Stereopsis and Vision-Related Quality of Life After Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: A Prospective Cohort StudyKamil Gazizov, Jeremy Pasco, Jean-Baptiste Ducloyer, et al.
Ophthalmology and Therapy|March 4, 2026
One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportAlice M Kitay, Anne Tillmann, Isabel Pfister, et al.
Pageof 139